logo Ampharco U.S.A
Preserving The Preciousness of Life
EN | VN
logo zalo

Company History

With more than 50 years of growth and development, Ampharco U.S.A takes pride in being a trusted name that has consistently contributed to the advancement of Vietnam’s pharmaceutical industry. Originating as Thai Van Pharmaceutical Company, Ampharco U.S.A served as the exclusive distributor for leading international pharmaceutical groups from France, Germany, and Italy. Early international partnerships laid the foundation for a vision of sustainable growth and a commitment to global quality standards. Through collaborations with multinational partners, Ampharco U.S.A benefited from technology transfer with Servier, further strengthening its capabilities and establishing a manufacturing facility that meets EU-GMP standards.

At the same time, enduring partnerships with domestic enterprises have allowed the company to expand its distribution network and create products tailored to local needs. Several of these, such as SOSLac G3, SOSCough, EzinAPC, and Amfagold G2 Plus,… have been warmly embraced by the market. Today, Ampharco U.S.A not only secures a strong position in Vietnam but also continues to strengthen its role as an active player in the global pharmaceutical landscape.

Ampharco Development History

Miles stone

2025

  • Received EU-GMP Certification for Factory B in March, 2025.
  • Total production capacity is around One Billion Galenic Units/year.
  • Five GSP Warehouses to be completed in 2026 (4 for lease, 1 for Company use).
  • Techonology transfer of 5 key Servier products to Ampharco U.S.A 

2021

Continue to expand and strengthen the position

  • Continued successful launch of OTC products- ranked as top sellers in Vietnam: SOSLacG3, EzinAPC, SOSCough, Nidal, Amfagold G2 Plus.
  • Continued expansion of hospital tender activities nationwide.

2020

Expanding activities in

  • R and D
  • Production
  • Sale and Marketing
  • Nationwide Distribution
  • Export

2017

  • Transferred over 120 SKU's to Sanofi in 2012 (99% of our existing drug portfolio)
  • OEM for Sanofi.
  • Develop and register new products for our new drug portfolio.

2012
2004

Establishment of Ampharco USA Pharmaceutical JSC

Successful launch of leading brands in Vietnam: Dipolac, Cezil, Mepraz, Bosamin,.

1969

The Forerunner of Ampharco U.S.A

Thai Van Labs Exclusive distributor of pharmaceutical products for companies in France (Allard), Germany(Kalichemie), Italy (Carlo Erba).